SPIA
SNNA

Steward Partners Investment Advisory’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Steward Partners Investment Advisory’s Portfolio SNNA Stock Details SNNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-300
Closed – – 3499
2021
Q2 		$0 Buy
+300
New – ﹤0.01% 7604

Steward Partners Investment Advisory's SNNA Position: Q3 2021 in Review

Steward Partners Investment Advisory sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q3 2021, closing a stake of 300 shares.

Steward Partners Investment Advisory first reported a position in SNNA in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 0 funds tracked by Wall St. Rank hold SNNA as of Q3 2021.

  • Steward Partners Investment Advisory reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 300 Sienna Biopharmaceuticals, Inc. shares in Q3 2021.
  • Steward Partners Investment Advisory first reported a position in Sienna Biopharmaceuticals, Inc. in Q2 2021 and held it in 1 quarter.
  • Steward Partners Investment Advisory's Sienna Biopharmaceuticals, Inc. position peaked at $0 in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q3 2021.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2021, filed 12 Nov 2021.